Tyra Biosciences, Inc. (TYRA) Misses Q4 EPS by 4c

Tyra Biosciences, Inc. (NASDAQ: TYRA) reported Q4 EPS of ($0.57), $0.04 worse than the analyst estimate of ($0.53).

For earnings history and earnings-related data on Tyra Biosciences, Inc. (TYRA) click here.

You May Also Be Interested In

• S&P shares jump report of potential CapIQ spinout
• Energy Vault’s 100 MW AI Infrastructure Project in Sardinia Receives Italian Government Designation as Project of Pre-Eminent National Strategic Interest
• Needham on Medtronic, Inc. (MDT): 'We believe that MDT is in the early stages of a strong product cycle'